Page last updated: 2024-09-04

edotreotide and Merkel Cell Cancer

edotreotide has been researched along with Merkel Cell Cancer in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balogova, S; Huchet, V; Kerrou, K; Michaud, L; Montravers, F; Nataf, V; Talbot, JN	1
Becker, JC; Bröcker, EB; Buck, AK; Buder, K; Goebeler, M; Herrmann, K; Kreissl, MC; Lapa, C; Schirbel, A; Schnack, A	1
Herrmann, R; Maecke, H; Meier, G; Mueller-Brand, J; Pless, M; Waldherr, C	1

Reviews

1 review(s) available for edotreotide and Merkel Cell Cancer

Article	Year
18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type. European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:6 Topics: 3-Iodobenzylguanidine; Bronchial Neoplasms; Carcinoma, Merkel Cell; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Recurrence; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon	2013

Article

Year

18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type.

European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:6

Topics: 3-Iodobenzylguanidine; Bronchial Neoplasms; Carcinoma, Merkel Cell; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Recurrence; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon

2013

Other Studies

2 other study(ies) available for edotreotide and Merkel Cell Cancer

Article	Year
Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging. BMC cancer, 2014, Apr-17, Volume: 14 Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Carcinoma, Merkel Cell; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Molecular Imaging; Octreotide; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Tomography, X-Ray Computed	2014
Successful targeted radiotherapy with 90Y-DOTATOC in a patient with Merkel cell carcinoma. A Case Report. Oncology, 2004, Volume: 66, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Merkel Cell; Cheek; Facial Neoplasms; Fatal Outcome; Female; Humans; Octreotide; Radiopharmaceuticals; Skin Neoplasms; Yttrium Radioisotopes	2004

Article

Year

Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging.

BMC cancer, 2014, Apr-17, Volume: 14

Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Carcinoma, Merkel Cell; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Molecular Imaging; Octreotide; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Tomography, X-Ray Computed

2014

Successful targeted radiotherapy with 90Y-DOTATOC in a patient with Merkel cell carcinoma. A Case Report.

Oncology, 2004, Volume: 66, Issue:2

Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Merkel Cell; Cheek; Facial Neoplasms; Fatal Outcome; Female; Humans; Octreotide; Radiopharmaceuticals; Skin Neoplasms; Yttrium Radioisotopes

2004